Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000904454-14-000410

10% owner acquired 72,690 shares (option exercise)

  • 10% owner gave up 46,876 shares (to pay taxes)
  • 10% owner acquired 1,724,478 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

JOHNSON & JOHNSON · 10% owner

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2014-05-01 Conversion : show line 1 in the form +1,724,478 1,724,478 I
2014-05-01 Exercise or conversion : show line 2 in the form +36,345 $5.16 $187,540 1,760,823 I
2014-05-01 Shares withheld for taxes : show line 3 in the form −23,438 $8.00 $187,504 1,737,385 I
2014-05-01 Exercise or conversion : show line 4 in the form +36,345 $5.16 $187,540 1,773,730 I
2014-05-01 Shares withheld for taxes : show line 5 in the form −23,438 $8.00 $187,504 1,750,292 I

Table II: Derivative

6 lines
Date Transaction Shares Owned after D/I
2014-05-01 Conversion : show line 6 in the form Series A Preferred Stock −385,800 0 I
2014-05-01 Conversion : show line 7 in the form Non-Voting Series A Preferred Stock −104,396 0 I
2014-05-01 Conversion : show line 8 in the form Series B Preferred Stock −427,591 0 I
2014-05-01 Conversion : show line 9 in the form Non-Voting Series B Preferred Stock −133,827 0 I
2014-05-01 Exercise or conversion : show line 10 in the form Series B Preferred Stock Warrant (Right to Buy) −36,345 0 I
2014-05-01 Exercise or conversion : show line 11 in the form Series B Preferred Stock Warrant (Right to Buy) −36,345 0 I
Loading xslF345X03/edgar.xml…